Jaguar Health (JAGX) EPS (Diluted) Growth (1y) (2021 - 2026)
Jaguar Health (JAGX) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 17,091.12% |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 61.58% |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | -7.16% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 96.09% |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 1,158.84% |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 97.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.67% |
| Dec 31, 2025 | 71.38% |
| Sep 30, 2025 | 76.15% |
| Jun 30, 2025 | 89.70% |
| Mar 31, 2025 | 80.83% |
| Dec 31, 2024 | 94.18% |
| Sep 30, 2024 | 95.25% |
| Jun 30, 2024 | 83.85% |
| Mar 31, 2024 | 97.58% |
| Dec 31, 2023 | 93.11% |
| Sep 30, 2023 | 95.75% |
| Jun 30, 2023 | 95.33% |
| Mar 31, 2023 | 92.31% |
| Dec 31, 2022 | 76.70% |
| Sep 30, 2022 | 54.36% |
| Jun 30, 2022 | 63.41% |
| Mar 31, 2022 | -49.77% |
| Dec 31, 2021 | 65.65% |
| Sep 30, 2021 | 63.15% |
| Jun 30, 2021 | 75.84% |